Paige
Drs. Eloy and Bryson Validate Paige Prostate Diagnostic AI in Clinical Setting
At the 2022 European Congress of Pathology (ECP) in Basel, Switzerland, Paige’s Medical Director Dr. Juan Retamero moderated a symposium featuring Dr. Catarina Eloy, Head of Pathology Lab at IPATIMUP ...
Paige Announces Partnership with Sonora Quest Laboratories to Accelerate Precision Diagnostics for Patients Across Arizona
NEW YORK–(BUSINESS WIRE)–Paige, a global leader in clinical AI applications for pathology, today announced it will partner with Sonora Quest Laboratories, the local market leader in clinical diagnosti...
Paige Answers Call to Better Identify Breast Cancer Patients with Low Expression of HER2
Company announces CE-IVD and UKCA designations of its new digital biomarker assay, HER2Complete, to identify patients with expression of HER2 in breast cancer The tool has revealed HER2 expression in ...
Paige Announces Collaboration with Janssen to Deploy a Novel AI-Based Biomarker Test for Advanced Bladder Cancer in Clinical Settings
Paige and Janssen will collaborate to deploy an AI-powered, H&E-based biomarker test, developed by Janssen, to screen for actionable FGFR2 and FGFR3 genomic alterations within seconds Goal is to p...
Paige AI Solution for Prostate Cancer Biomarker Detection Receives CE-IVD and UKCA Marks
First European regulatory clearance for Paige’s digital biomarker capabilities May 12, 2022 10:05 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Paige, a global leader in clinical AI ap...
Paige Announces Expansion of Scientific Advisory Board
Paige Announces Expansion of Scientific Advisory Board Six new advisors include leading experts in pathology, oncology, deep learning and global biopharmaceutical industry May 04, 2022 10:04 AM E...
Ultivue Announces Co-Marketing and Co-Development Collaboration with Paige for AI-Powered Biomarker Imaging Solutions for Precision Medicine
Ultivue, an industry leader in multiplexing tools for tissue biomarker analysis, and Paige, the global leader in AI-based diagnostic software in pathology, today announced a partnership to collaborate...
Paige Earns CE-IVD and UKCA Marks for Clinical AI Application to Detect Breast Cancer Metastases in Lymph Nodes
Paige now holds six CE marks in its portfolio of clinical AI applications Paige Breast Lymph Node was first launched at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting in Ma...
Paige Launches AI Software to Enable Accurate and Efficient Detection of Breast Cancer Metastases in Lymph Nodes
NEW YORK–(BUSINESS WIRE)–Paige, the global leader in AI-based diagnostic software in pathology, today launched its latest product, Paige Breast Lymph Node, an AI medical device software that helps pat...